Magnesium for Anxiety: What the Clinical Trials Show
Magnesium for anxiety is one of the more scientifically grounded corners of supplement research: it blocks the excitatory NMDA receptor and dampens the cortisol stress response, and trials show modest real benefit — though far less than established drug or talk therapies. The 2017 Boyle review of 18 studies and a 2017 RCT of 264 mildly stressed adults (300 mg/day, alone or with vitamin B6, cutting stress scores over 8 weeks) both found the effect is largest in people with mild symptoms or low magnesium status, appearing over 2–6 weeks. Well-absorbed forms — glycinate, citrate, or threonate at about 200–400 mg elemental magnesium — are preferred over poorly absorbed oxide, with loose stools the main dose-limiting effect. It is a reasonable option for everyday stress and a useful sleep-quality knock-on, but not a substitute for proper treatment of moderate-to-severe generalised anxiety or panic disorder.
Anxiety disorders affect over 300 million people globally, and interest in magnesium as a nutritional intervention has grown substantially as the mechanistic rationale has become clearer and trial evidence has accumulated.
Why Magnesium Might Affect Anxiety
Magnesium is a physiological antagonist of the NMDA receptor, one of the primary excitatory glutamate receptors in the brain. Magnesium blocks the NMDA channel at resting membrane potential, moderating excitatory neurotransmission. This mechanism partially overlaps with the action of ketamine, an NMDA antagonist with established anxiolytic effects. Magnesium also modulates the HPA axis stress response, with deficiency associated with exaggerated cortisol reactions to stressors. Magnesium deficiency affects roughly 48% of Americans based on dietary intake data.
Effect sizes across placebo-controlled trials
The Clinical Trial Evidence
The 2017 systematic review by Boyle, Lawton and Dye in Nutrients identified 18 studies (8 RCTs and 10 quasi-experimental designs) examining magnesium and subjective anxiety or stress outcomes. Most RCTs reported modest improvements in self-reported anxiety, but the trials were generally small, short (often 6–8 weeks), and in people with mild symptoms or borderline-low magnesium status. The 2017 RCT by Pouteau et al. of 264 mildly stressed adults with low magnesium status showed that 300 mg/day of magnesium (alone, or with vitamin B6) for 8 weeks reduced perceived-stress (DASS-42) scores significantly more than placebo, with the largest effect in participants under the most severe stress. Effects typically appear over 2–6 weeks. Magnesium is not a substitute for evidence-based treatments in moderate-to-severe generalised anxiety disorder or panic disorder.
Practical Guidance
Glycinate, citrate, and threonate forms have the best absorption and CNS-relevant evidence; doses used in anxiety trials range from about 200–400 mg elemental magnesium daily. Loose stools are the main dose-limiting side effect, and the effect is most pronounced with magnesium oxide and citrate.
Sources
- Boyle NB, Lawton C, Dye L. "The Effects of Magnesium Supplementation on Subjective Anxiety and Stress — A Systematic Review." Nutrients, 2017;9(5):429. PMID: 28445426. DOI: 10.3390/nu9050429.
- Pouteau E, Kabir-Ahmadi M, Noah L, Mazur A, Dye L, Hellhammer J, Pickering G, Dubray C. "Superiority of magnesium and vitamin B6 over magnesium alone on severe stress in healthy adults with low magnesemia: A randomized, single-blind clinical trial." PLoS ONE, 2018;13(12):e0208454. PMID: 30562392. DOI: 10.1371/journal.pone.0208454.
- Pickering G, Mazur A, Trousselard M, Bienkowski P, Yaltsewa N, Amessou M, Noah L, Pouteau E. "Magnesium Status and Stress: The Vicious Circle Concept Revisited." Nutrients, 2020;12(12):3672. PMID: 33260549. DOI: 10.3390/nu12123672.
- de Baaij JHF, Hoenderop JGJ, Bindels RJM. "Magnesium in Man: Implications for Health and Disease." Physiological Reviews, 2015;95(1):1–46. PMID: 25540137. DOI: 10.1152/physrev.00012.2014.
Reviewed against 4 peer-reviewed sources.